Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit

M. D. Algera, W. J. van Driel, B. F. M. Slangen, M. W. J. M. Wouters, R. F. P. M. Kruitwagen, A. J. Kruse, R. Yigit, M. J. A. Engelen, L. S. Nooij, J. W. M. Mens, M. A. A. de Jong, M. A. D. Haverkort, M. van der Aa, J. Diepstraten, M. A. P. C. van Ham, H. P. M. Smedts, N. Reesink, K. N. Gaarenstroom, P. M. L. H. Vencken, D. BollG. Fons, A. Baalbergen, E. B. L. van Dorst, E. M. Roes, H. T. C. Nagel, A. van Ginkel, J. de Waard, On behalf of the participants of the Dutch Gynecological Oncology Audit Collaborator Group

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective: Despite lacking clinical data, the Dutch government is considering increasing the minimum annual surgical volume per center from twenty to fifty cytoreductive surgeries (CRS) for advanced-stage ovarian cancer (OC). This study aims to evaluate whether this increase is warranted. Methods: This population-based study included all CRS for FIGO-stage IIB-IVB OC registered in eighteen Dutch hospitals between 2019 and 2022. Short-term outcomes included result of CRS, length of stay, severe complications, 30-day mortality, time to adjuvant chemotherapy, and textbook outcome. Patients were stratified by annual volume: low-volume (nine hospitals, <25), medium-volume (four hospitals, 29–37), and high-volume (five hospitals, 54–84). Descriptive statistics and multilevel logistic regressions were used to assess the (case-mix adjusted) associations of surgical volume and outcomes. Results: A total of 1646 interval CRS (iCRS) and 789 primary CRS (pCRS) were included. No associations were found between surgical volume and different outcomes in the iCRS cohort. In the pCRS cohort, high-volume was associated with increased complete CRS rates (aOR 1.9, 95%-CI 1.2–3.1, p = 0.010). Furthermore, high-volume was associated with increased severe complication rates (aOR 2.3, 1.1–4.6, 95%-CI 1.3–4.2, p = 0.022) and prolonged length of stay (aOR 2.3, 95%-CI 1.3–4.2, p = 0.005). 30-day mortality, time to adjuvant chemotherapy, and textbook outcome were not associated with surgical volume in the pCRS cohort. Subgroup analyses (FIGO-stage IIIC-IVB) showed similar results. Various case-mix factors significantly impacted outcomes, warranting case-mix adjustment. Conclusions: Our analyses do not support further centralization of iCRS for advanced-stage OC. High-volume was associated with higher complete pCRS, suggesting either a more accurate selection in these hospitals or a more aggressive approach. The higher completeness rates were at the expense of higher severe complications and prolonged admissions.

Original languageEnglish
Pages (from-to)144-153
Number of pages10
JournalGynecologic Oncology
Volume186
DOIs
Publication statusPublished - 1 Jul 2024

Keywords

  • Advanced-stage ovarian cancer
  • Clinical auditing
  • Complete cytoreduction
  • Cytoreductive surgery
  • Length of stay
  • Mortality
  • Postoperative complications
  • Surgical volume
  • Textbook outcome

Cite this